Experiences with Oxford–AstraZeneca COVID-19 vaccine (Covishield, Vaxzevria)

This page shows detailed information about a medicine such as statistics, patient reviews and related articles.

Active ingredient: COVID-19 recombinant vaccine
ATC Code: J07BX03
reviews
Oxford–AstraZeneca COVID-19 vaccine (Covishield, Vaxzevria)
ATC Code: J07BX03, Active ingredient: COVID-19 recombinant vaccine

Level of
Satisfaction

Level of Satisfaction 100%

What patients say...

Effectiveness 100%
Quantity of side effects 0%
Severity of side effects 0%
Ease of use 100%

Our patients

Our patients, demographics

Read our patient's reviews about Oxford–AstraZeneca COVID-19 vaccine (Covishield, Vaxzevria)

Filter reviews by...

hide filters...
translation feature available for reviews from other countries

Oxford–AstraZeneca COVID-19 vaccine (Covishield, Vaxzevria)

28/01/2022 | | 78moderated by Charlotte
COVID-19 recombinant vaccine (0,5 ml) for Coronavirus

No problem what so ever. Went back to work!
> read full review...

Most reviewed medicines


The content on this page is user-generated content, read and revised before approval to comply with our standards for a medicine review or reaction. We do not enforce any proven medical knowledge from our users to allow them to present their experiences. This way, the opinions and experiences described state only the views of the writers and not those of the owner of this website. Remember that these experiences differ from person to person and that you should always contact your doctor or pharmacist for advice on medication.

Copyright © 2008-2022 Insight Pharma Services BV.
All rights reserved.
Most icons from FontAwesome. Some icons made by Prosymbols from www.flaticon.com and licensed as CC 3.0 BY.